Pol is an error-prone DNA polymerase that is critical for embryonic development and maintenance of genome stability. To analyze its suggested role in somatic hypermutation (SHM) and possible contribution to DNA double-strand break (DSB) repair in class switch recombination (CSR), we ablated Rev3, the catalytic subunit of Pol , selectively in mature B cells in vivo. The frequency of somatic mutation was reduced in the mutant cells but the pattern of SHM was unaffected. Rev3-defi cient B cells also exhibited pronounced chromosomal instability and impaired proliferation capacity. Although the data thus argue against a direct role of Pol in SHM, Pol defi ciency directly interfered with CSR in that activated Rev3-defi cient B cells exhibited a reduced effi ciency of CSR and an increased frequency of DNA breaks in the immunoglobulin H locus. Based on our results, we suggest a nonredundant role of Pol in DNA DSB repair through nonhomologous end joining.
In T cell -dependent antibody responses, B cells are triggered to undergo a second round of antibody diversifi cation in germinal centers (GCs) ( 1 ) . Somatic hypermutation (SHM) introduces mutations into rearranged variable (V) regions of Ig genes allowing antibody affinity maturation ( 2, 3 ), whereas class switch recombination (CSR) exchanges the Ig constant (C) region to modify the eff ector function of the antibody ( 4 ). Both SHM and CSR rely on activation-induced deaminase (AID), an enzyme which deaminates cytidine residues in single-stranded DNA ( 5 ) . The DNA deamination model of SHM suggests the conversion of G-C basepairs into G-U mismatches within the V region by AID ( 6, 7 ) , which are subsequently processed in one of three ways: direct replication across the G-U mismatches results in G-C to A-T mutations; the removal of the uracil residues by the uracil deglycosylase UNG creates abasic sites, and DNA synthesis by error-prone DNA polymerases generates additional mutations; or the recognition of the G-U mismatches by the mismatch repair enzymes MSH2 and MSH6 leads to subsequent error-prone short-patch DNA synthesis, which introduces mutations outside the initial site of the lesion.
In the case of CSR, it is widely believed that upon cytidine deamination by AID, staggered DNA double-strand breaks (DSBs) are generated by the removal of the uracil residues by UNG, followed by the cleavage of the abasic sites by APE1/2 during the G1 phase of the cell cycle ( 5, 8 -13 ) . Alternatively, the mismatch -repair pathway can lead to the generation of staggered DSBs via the recognition of uracil by mutation ( 43 ) . Two targeted embryonic stem (ES) cell clones were injected into blastocysts. Mice carrying the fl oxed Rev3 allele (subsequently called Pol f ) were viable and born at Mendelian ratios. The correct targeting of the Rev3 locus was confi rmed by a nested PCR assay on tail DNA from Pol f/+ mice and wild-type controls. The PCR relied on a forward primer located outside the targeting vector to ensure the integration of the latter into the Rev3 locus, and a reverse primer located 3 Ј of the downstream loxP site. The amplicons of both the wild-type and fl oxed alleles migrated at the expected size of ‫ف‬ 5.2 kb (unpublished data). The PCR products were then gel purifi ed and used as templates for two separate PCRs that amplifi ed across the fi rst and second loxP site, respectively. Each PCR amplifi ed only one band for wild-type mice. In Pol f/+ mice, however, an additional band appeared in both cases whose larger size was consistent with the presence of an inserted loxP site ( Fig. 1 C ) . Mice carrying the Pol f allele were intercrossed with CD21-cre or deleter mice to generate Pol f/ ⌬ /CD21-cre compound mutants, in which Pol function was specifi cally inactivated in mature B cells ( 44, 45 ) . The deletion of exon 2 in the Pol ⌬ allele was confi rmed by gene amplifi cation and subsequent sequencing of the PCR product (unpublished data).
Immune response and GC formation in Pol f/ ⌬ /CD21-cre mice
No defects in B cell development were observed in Pol f/ ⌬ / CD21-cr e mice (unpublished data). Likewise, the number and proportions of resting B cells in the periphery was indistinguishable from those in control mice (unpublished data). We then characterized the antibody response of Pol f/ ⌬ / CD21-cre mice against the T cell -dependent antigen NP-CG (3-hydroxy-nitrophenyl acetyl coupled to chicken ␥ -globulin). We injected Pol f/ ⌬ /CD21-cre mice and control animals with 100 μ g NP-CG in alum intraperitoneally and measured the serum titers of the NP-specifi c IgG1 and Ig antibodies at days 7 and 14 after immunization. At both time points, the response of Pol f/ ⌬ /CD21-cre mice was reduced by 50% compared with that of control mice (unpublished data). Pol defi ciency may aff ect cell viability of highly proliferating cells such as GC B cells. We therefore compared the proportions of CD19 + Fas + PNA high GC B cells in spleen, mesenteric lymph nodes, and Peyer ' s patches of Pol f/ ⌬ /CD21-cre and control mice that had been immunized with 100 μ g NP-CG in alum 14 d earlier. The GC B cell compartment of Pol f/ ⌬ / CD21-cre mice was 2 -3-fold smaller than that in control animals ( Fig. 2 A ) , suggesting an impairment of cell proliferation or cell viability in the absence of Pol . To test whether this resulted in an accumulation of B cells that had escaped Cremediated inactivation of Pol , we isolated CD19 + Fas + PNA high GC B cells and CD19 + Fas Ϫ PNA low naive B cells from Pol f/ ⌬ / CD21-cre mice and control mice 14 d after immunization by fl ow cytometry and determined the deletion effi ciency of the Pol f allele in these cells by PCR. Competitive amplifi cation of the Pol f and Pol ⌬ alleles and comparison to a standard curve with known ratios of the two alleles showed that ‫ف‬ 90% of the PCR products in the CD19 + Fas Ϫ PNA low B cell MSH2 and MSH6 ( 8, 14, 15 ) . The DSBs are then resolved by a process that includes DNA damage response proteins such as H2AX, MDC1, ATM, 53BP1, and the Nibrin -Mre11 -Rad50 complex, the mismatch repair enzymes Pms2 and Mlh1, the exonuclease Exo1, and the classical and alternative nonhomologous end-joining (NHEJ) machinery ( 16 -28 ) .
Although the DNA polymerases required for fi lling in the staggered DNA breaks generated in CSR have not been identified, a possible involvement of several error-prone DNA polymerases in SHM has been tested using both hypermutating cell lines and KO mice defi cient of these enzymes. From this work, Pol , Pol , and perhaps Pol have emerged as important components of the SHM mechanism, whereas Pol ␤ , Pol , Pol , and Pol do not appear to play a significant role ( 29 -35 ) . Pol is an error-prone DNA polymerase that is characterized by its ability to extend mismatched primer-template termini ( 36 ) . Pol , together with Pol , has been suggested as the prime example of the two-step inserterextender model of translesion synthesis, in which a fi rst DNA polymerase (Pol ) synthesizes across the DNA lesion and a second polymerase (Pol ) extends the resulting mismatch ( 36 ) . These features highlighted Pol as an additional candidate enzyme of the SHM machinery. Indeed, studies in a hypermutating cell line and a transgenic mouse strain that express antisense RNA against Rev3, the catalytic subunit of Pol , demonstrated a reduction of the frequency of somatic mutations in rearranged Ig V region genes, suggesting an involvement of Pol in SHM ( 37, 38 ) .
Attempts to address this issue in vivo by genetically ablating Pol in mice have been hampered by the embryonic lethality observed upon deletion of the Pol gene in the mouse germ line ( 39 -41 ) . This embryonic lethality could be a result of the pronounced genomic instability observed upon Pol ablation in a wide variety of cellular systems ( 42 ) , in turn suggesting a role of this enzyme in DNA repair and thus, potentially, CSR ( 16 ) . To assess a possible contribution of Pol to SHM and CSR in vivo, we generated mice that carry a deletion of Rev3 selectively in mature B cells (subsequently called Pol f/ ⌬ /CD21-cre mice). In this paper, we show that Pol -defi cient B cells are impaired in their ability to proliferate and to maintain a stable genome. The mutant cells fail to undergo an effi cient GC reaction and exhibit a reduced frequency of SHM and impaired CSR. The CSR defect is associated with an increased frequency of aberrantly or unrepaired DNA breaks within the IgH locus, suggesting that Pol plays a nonredundant role in DNA DSB repair through NHEJ.
RESULTS

Generation of a conditional Pol allele
This was achieved by fl anking exon 2 of the Rev3 gene by loxP sites, to allow its deletion by Cre-mediated recombination ( Fig. 1, A and B ) . Exon 2 is the second coding exon of Rev3 , and messenger RNA splicing from exon 1 to exon 3 results in a frameshift mutation. Some Rev3 transcripts incorporate an additional exon downstream of exon 1. RNA splicing from this exon to exon 3 also results in a frameshift in the mutants, a substantial fraction of these cells had escaped Cre-mediated recombination. An analysis of VDJ joints amplifi ed from populations of such cells is a priori compromised. Indeed, when we analyzed the accumulation of somatic mutations by bulk PCR using a primer pair that anneals in the framework region 3 of most V H J558 gene segments and in the intron downstream of the J H 4 gene segment ( 46 ) , we found only a moderate reduction of the frequency of SHM in the mutants compared with the controls (Fig. S1 A, available at http:// www.jem.org/cgi/content/full/jem.20080669/DC1). 76 and 79% of the mutations in Pol f/ ⌬ /CD21-cre mice occurred at fraction and 80% in the CD19 + Fas + PNA high B cell fraction were derived from the Pol ⌬ allele in Pol f/ ⌬ /CD21-cre mice ( Fig. 2 B ) . This corresponds to a deletion effi ciency of 80% in naive and 60% in GC B cells, as the mice were heterozygous for the Pol ⌬ allele. Thus, there was a moderate enrichment of cells that failed to inactivate Pol in the GCs. Bold lines, regions of homology; black boxes, exons; gray boxes, selection markers; tk, thymidine kinase gene; neo r , neomycin resistance gene; triangles, loxP sites; B, BamHI sites; E, EcoRI sites. The predicted sizes of DNA fragments detected by Southern blot hybridization with probe A or probe B on EcoRI and BamHI-digested genomic DNA, respectively, as well as the location of the primers polz-1 to polz-6 for the genomic PCRs (short arrows) are indicated. The map is not drawn to scale. (C) Analysis of the targeted rev3 locus. The wild-type and targeted alleles were distinguished by nested PCRs on tail DNA from Pol +/f and wild-type mice. The fi rst PCR round relied on primers 1 and 2 that anneal 5 Ј of the region of homology and 3 Ј of the second loxP site, respectively. This was followed by an amplifi cation step of the gel-purifi ed PCR product using the primer pairs 3 and 4 or 5 and 6, which fl ank the fi rst and second loxP site, respectively. For primer pair 3 and 4, the expected sizes of the wild-type and targeted PCR products are 523 and 583 bp. For primer pair 5 and 6, the expected sizes are 384 and 458 bp. There was no diff erence in the ratio of transitions to transversions between mutants and controls ( Fig. S1 B) .
To approach the impact of Pol defi ciency on SHM at a higher level of resolution, we analyzed the accumulation of somatic mutations in Pol f/ ⌬ /CD21-cre mice at the level of single GC B cells, which we simultaneously genotyped for the inactivation of the Pol gene. This approach off ered an additional advantage in that it is not sensitive to a diff erent rate of PCR errors across the individual samples. We isolated single GC B cells by fl ow cytometry and performed a PCR using a primer pair that anneals in the framework region 3 of most V H J558 gene segments and in the intron downstream of the To compare the pattern of somatic mutations in mutants and controls, we fi rst established the mutation patterns in the individual introns downstream of each rearranged J H gene segment. Subsequently, we normalized the mutation patterns to the base composition of the respective intron and then combined the mutation patterns of all four introns. There was no signifi cant diff erence in the mutation pattern between their Ig genes with a frequency of 0.19% ( Fig. 3 A ) . In contrast, the mutation frequency in GC B cells that had retained the Pol f allele was 0.68%. Moreover, almost 50% of all sequences derived from Pol ⌬ / ⌬ cells contained only one mutation, whereas close to 80% of the sequences derived from Pol f/ ⌬ cells had multiple mutations. Likewise, 38% of the sequences derived from Pol ⌬ / ⌬ cells remained unmutated. Pol f/ ⌬ and Pol ⌬ / ⌬ GC B cells. In Pol ⌬ / ⌬ cells, 62% of all mutations accumulated at A-T basepairs, which compared with 61% for Pol f/ ⌬ cells ( Fig. 3 , B and C ). Likewise, the ratio of transitions to transversions was not altered. We conclude from these data that Pol defi ciency has no impact on the pattern of SHM and that the diff erences in the A-T mutations observed in the bulk analysis must have been a result of diff erences in the fi delity of gene amplifi cation between the experimental groups, a possibility which is excluded in the single cell analysis. With respect to the frequency of SHM, two interpretations off er themselves to explain the results: Pol defi ciency either directly impacts the SHM mechanism or it results in a rapid arrest of cellular proliferation preventing further SHM. The absence of a change of mutation pattern favors the latter interpretation. germline S and S ␥ 3 sequences and counted the number of nucleotides at the S junctions that were identical to both the S and S ␥ 3 region. The majority (53%) of the sequences derived from Pol +/ ⌬ /CD21-cre B cells displayed little (1 -2 nt) or no microhomology at the S junctions, whereas a smaller fraction (21%) of sequences exhibited a longer stretch (3 -7 nt) of nucleotide overlap ( Fig. 4 C ) . The remaining fraction (25%) had insertions of 1 nt or more at the S junctions. Similar to the control cells, the majority of sequences (56%) derived from Pol f/ ⌬ /CD21-cre B cells contained no or only small microhomologies. In contrast, the frequency of sequences containing microhomologies of 3 -7 nt was increased (34%), whereas the frequency of sequences containing insertions was reduced (10%). Insertions of 2 nt or longer were absent in sequences from the mutant B cells in contrast with control sequences. The changes in the nature of the S -S ␥ 3 junctions, albeit modest, are consistent with a possible requirement for Pol in the effi cient processing of free DNA ends during CSR.
We also analyzed the switch junctions for somatic point mutations, which are known to occur in these regions through the recruitment of AID in the initiation of CSR ( 13, 50 ) . In cells initiating but not completing CSR in the course of proliferate. The percentages of class-switched cells were also 2 -3-fold reduced when cells having undergone a similar number of divisions were analyzed for CSR ( Fig. 4 A , gate indicated by red bracket). The latter result was independent of the location or width of the gate.
Germline transcription of the S regions is required for the initiation of CSR. Hence, we asked whether diff erences of germline transcription could account for the impairment of CSR in Pol f/ ⌬ /CD21-cre B cells. We stimulated splenic B cells with either LPS + IL-4 or LPS alone for 2 d and then amplifi ed germline transcripts of S , S ␥ 1, and S ␥ 3 by RT-PCR. Pol f/ ⌬ /CD21-cre and control B cells produced similar levels of S , S ␥ 1, and S ␥ 3 transcripts ( Fig. 4 B ) . To test whether Pol is required for the repair phase of CSR, we amplifi ed and sequenced S -S ␥ 3 junctions from mutant and control cells, as it is known that the inactivation of some genes involved in DNA repair, such as MSH2, PMS2, or Pol , can lead to changes in the nature of the microhomologies or mutations at the junctions between the S and S ␥ 3 or other S regions in class-switched cells ( 15, 19, 48, 49 ) . PCR products between 500 and 800 nt were selected for analysis, subcloned, and sequenced, excluding clonally related cells. We then analyzed the sequences by BLAST alignment to the ( Fig. 5 A ) . Chromosomal abnormalities were observed in 3% of the metaphases proliferation, such mutations are introduced into S μ but are rarely found in S ␥ 1 or S ␥ 3. It is believed that this explains the higher load of mutations in the S μ parts of S -S ␥ 1 or -S ␥ 3 switch junctions ( 24, 49, 50 ) . Comparing the sequences of S -S ␥ 3 junctions within a 200-bp window, we found that in wild-type cells the mutation frequencies in the S μ portions of the junctions were indeed higher than in S ␥ 3 portions (0.53 and 0.27%, respectively), whereas in the mutants they were similarly low (0.21 and 0.22%, respectively; Table S1 , available at http://www.jem.org/cgi/content/full/ jem.20080669/DC1). The limited number of mutations did not allow a meaningful comparison of the mutation pattern.
These results indicate that somatic mutations were equally introduced in mutant and control cells into switch regions undergoing switch recombination but that because of im- Fig. 7 ). Spectral karyotyping (SKY) confi rmed the general chromosomal instability detected in Pol -defi cient B cells ( Fig. 5 B ) . Consistent with the previous analysis, only a modest number (5%) of metaphases of B cells from control mice contained irregular chromosomes, whereas metaphases containing broken chromosomes, chromosome fusions, and translocations were much more frequent (23%) in B cells of Pol f/ ⌬ /CD21-cre mice stimulated in vitro with LPS + IL-4 for 3 d. Even though Pol -defi cient metaphases were present with a broken chromosome 12, which carries the IgH locus in the mouse and where CSR occurs, other chromosomes (namely chromosomes 1, 3, and 11) were aff ected at a similar under these conditions ( Fig. 6 , B and C ; and Table I ) . We conclude that the increased frequency of chromosomal breaks in the IgH loci in B cells from Pol f/ ⌬ /CD21-cre mice after ␣ -CD40 mAb + IL-4 stimulation is a result of defective repair of CSR-induced DSBs.
DISCUSSION
Ubiquitous Pol defi ciency in the mouse is embryonic lethal ( 39 -41 ) . We have overcome this lethality by generating a conditional allele of Rev3 and used this allele to render mature resting CD21-expressing B cells defi cient of Pol . Using this system, we show that Pol is not essential for B cell maintenance but is required for proper B cell proliferation, presumably because of its role in the maintenance of genome stability. The genomic instability and proliferation defect of Pol -defi cient B cells observed in the present study is reminiscent of the phenotype of Pol -defi cient chicken DT40 B cells, which also accumulate genomic aberrations and are impaired in their ability to proliferate ( 52 ). Genomic instability was also observed in Pol -defi cient mouse embryonic fibroblasts, which barely divide and require inactivation of p53 to proliferate ( 51 ) . It has been speculated that Pol may prevent the collapse of replication forks that have stalled at DNA lesions and may facilitate postreplication DNA repair via homologous recombination or translesion synthesis and mismatch extension ( 42, 51 ) . However, the role of Pol in the maintenance of genome stability has not been determined with precision. Many components of the NHEJ or DNA damage response machinery do not aff ect proliferation and SHM ( 24, 28, 54 ) . B cells defi cient of the classical NHEJ factors Xrcc4 and ligase 4 harbor predominantly chromosome breaks, which are indicative of failed DSB repair in the G1 phase of the cell cycle ( 23 ) . In contrast, we found high frequencies of both chromosome and chromatid breaks in the Pol -defi cient B cells, indicating pre-and postreplication repair defects, respectively. It is thus also conceivable that the impaired proliferation and reduced cell viability of Pol -deficient B cells are a result of a function of Pol in NHEJ, translesion synthesis, and homologous recombination. Genomic instability and impaired proliferative capacity of Pol -defi cient B cells are likely the main reasons for the impaired GC and IgG1 antibody response in our mutant animals, in which Pol was selectively ablated in mature B cells. GCs were reduced in size, the frequency of somatic mutations introduced into V region genes was reduced, and CSR was impaired. We also observed counterselection of cells that had undergone deletion of the Rev3 gene in GCs. Analyzing the extent and pattern of SHM in Pol -profi cient and -deficient GC B cells by single cell PCR, we found a > 3.5-fold reduction of the frequency of somatic mutations in the mutant cells but no change in the mutational pattern. Given that Pol has been identifi ed as the sole polymerase responsible for mutations at A-T basepairs ( 55 ), a contribution of Pol to SHM should have resulted in a change of the mutational pattern in Pol -defi cient B cells. In the absence of such a change, our results are consistent with the interpretation that the 53 versus 13% of all metaphases of B cells from Pol f/ ⌬ /CD21-cre and control ( Pol f/+ / CD21-cre ) mice, respectively ( Fig. 6 and Table I ). The chromosomal breaks in B cells from both Pol f/ ⌬ /CD21-cre and control ( Pol f/+ / CD21-cre ) mice consisted of approximately equal proportions of chromatid and chromosome breaks ( Fig. 7 and Table S2 ). The results in Table S2 also raise the possibility that Pol haploinsuffi ciency aff ects genome stability in cells activated to undergo CSR, but more data would be required to fi rmly establish this point.
To assay for breaks or translocations within the IgH locus, we used a FISH assay in which the fi rst probe recognizes sequences just upstream of the IgH V H domain on the telomeric region of chromosome 12 (5 Ј Igh probe) and the second probe sequences immediately downstream of the C H locus (3 Ј Igh probe) ( 26 ) . This assay revealed chromosomal breaks within the IgH locus, visualized as separated 3 Ј and 5 Ј IgH signals, in 8.3% of metaphases from ␣ -CD40 mAb + IL-4 -activated B cells from Pol f/ ⌬ / CD21-cre mice. This is in contrast with only 2% of metaphases containing such breaks in activated control B cells ( Fig. 6 and Table I ). The breaks led to IgH locus-specifi c translocations in 28% of the aff ected cells from Pol f/ ⌬ / CD21-cre mice and in 43% of aff ected control B cells (unpublished data). These fi ndings suggest that Pol is required for repair of a subset of IgH locus breaks that occur during CSR.
To ensure that the enhancement of IgH breaks in activated Pol f/ ⌬ /CD21-cre B cells is indeed caused by CSR, we also stimulated B cells from Pol f/ ⌬ /CD21-cre and control mice with an ␣ -CD40 or ␣ -RP105 mAb alone because such treatments induce proliferation but not CSR ( 53 ) . Although B cells of Pol f/ ⌬ /CD21-cre mice again accumulated chromosomal aberrations at a higher level than the control cells, IgH locus-specifi c breaks were not detected in either cell type stimulated to undergo CSR are the result of a targeted rather than a random process. In further support of this notion, we failed to observe chromatid breaks at the IgH locus in metaphases of Pol -defi cient cells (in contrast with their frequent occurrence at other loci), suggesting that, specifi cally within the IgH locus, Pol functions to repair a subset of DSBs restricted to prereplicative stages of the cell cycle (G1) precisely when AID is known to target S regions ( 13, 56 ) . In principle, an increased frequency of IgH locus-specifi c DNA breaks could also result from defective V(D)J recombination. This has been recently observed in ATM-defi cient B cells, which accumulate such breaks in an AID-independent and RAGdependent manner ( 53 ) . Because the CD21-cre allele causes the deletion of the fl oxed Pol allele in mature but not developing B cells ( 44 ) and no IgH locus-specifi c DNA breaks were detected in Pol -defi cient B cells stimulated with ␣ -CD40 or ␣ -RP105 mAbs, such a possibility seems to be excluded in the present context.
CSR involves the generation of staggered DSBs during the G1 phase of the cell cycle, which need to be processed to create blunt DNA ends that serve as substrates for the alternative and classical NHEJ machinery ( 13, 23, 56 -58 ) . This processing requires the activity of exonucleases and DNA polymerases, with the former being provided by exonuclease 1 among perhaps other enzymes ( 20 ) . The present results suggest that Pol catalyzes fi ll-in reactions in the course of CSR-associated DSB repair by NHEJ. This is in line with observations in Saccharomyces cerevisiae that ATR homologue Mec1-dependent phosphorylation, which plays a major role in DNA damage checkpoint responses, promotes the association of Pol /Rev1 with DSBs ( 59, 60 ). Our observation that CSR is impaired in the absence of Pol , yet not completely abolished, points to the participation of additional polymerases in the repair phase of CSR. These could include Pol and Pol , both of which have been suggested to operate in classical NHEJ ( 61, 62 ) .
In normal B cells undergoing CSR, strict dosing of AID and effi cient repair by NHEJ prevents aberrant rejoining of IgH locus-specifi c DSBs to DSBs within other loci. Dysregulation of AID activity or defi ciency of specifi c repair factors has been shown to increase the frequency of oncogenic IgH-myc translocations in in vitro cultured primary B cells undergoing CSR ( 27 ) . In this context, we report frequent chromosomal translocations involving the IgH locus (and multiple uncharacterized partners) in primary Pol -defi cient B cells undergoing CSR in vitro. We also observed a slight trend toward increased genomic instability in Pol f/+ /CD21-cre heterozygous B cells compared with wild-type B cells (Table S2) . Thus, genetic or epigenetic alterations that result in Pol (haplo) insuffi ciency might act in vivo to increase the frequency of oncogenic IgH locus translocations.
MATERIALS AND METHODS
Targeting vector and generation of gene-targeted mice. A 25-kb clone comprising 4 exons of rev3 was obtained by screening a P1 library generated from C57BL/6 genomic DNA. The clone was used to construct impairment of SHM by Pol defi ciency is caused by the impaired cell viability and consequent counterselection of the mutant cells in the GC reaction.
In two earlier papers a direct involvement of Pol in the mechanism of SHM had been suggested ( 37, 38 ) . In one approach, Diaz et al. ( 37 ) constitutively expressed antisense RNA against Pol in transgenic mice and observed compromised SHM in the absence of a change of mutational pattern, which is similar to the present data. Although these results were diffi cult to interpret because of the non -B cell-autonomous expression of the transgenic antisense RNA and possible genomic instability also in that system, a study of SHM in a Burkitt lymphoma cell line again demonstrated a reduced frequency of somatic mutation upon transfection of the cells with Rev3-specifi c antisense oligonucleotides, without an eff ect on the mutation pattern ( 37, 38 ) . Rev3 expression was only partially inhibited in these experiments, and cell proliferation was not detectably aff ected. It remains to be seen to which extent these latter experiments refl ect the requirements for SHM in GC B cells in vivo, where a direct participation of Pol in its control clearly remains tentative.
In contrast with SHM, where our results suggest indirect eff ects of Pol defi ciency, our data indicate a direct involvement of Pol in CSR. We observed a reduction in CSR efficiency of Pol -defi cient B cells compared with control B cells even when we compared cells that had gone through the same number of cell divisions. Together with the observation that germline transcription of the S regions remains unaffected in Pol f/ ⌬ /CD21-cre mice, this suggested an involvement of Pol in the repair phase of CSR, a notion which was directly supported by the increased frequency of IgH locusspecifi c DNA breaks in Pol -defi cient B cells undergoing CSR in response to anti-CD40 stimulation in the presence of IL-4. Our evidence clearly indicates that these breaks were caused by a defective CSR process because they were absent in Pol -defi cient B cells activated with ␣ -CD40 or ␣ -RP105 mAbs alone, an activation protocol which induces proliferation but not CSR. Among 1,200 chromosomes analyzed by telomere FISH from individual ␣ -CD40 + IL-4 cultures, ‫ف‬ 3% of the chromosomes from Pol -defi cient B cells showed abnormalities including chromatid breaks, chromosome breaks, and chromosome fusions ( Fig. 7 , Table I , and Table S2 ). However, telomere FISH does not distinguish between CSR-specifi c and -unspecifi c chromosomal aberrations. To approach this problem, we determined the frequency of such CSR-specifi c breaks in the activated Pol -defi cient cells within the IgH locus on chromosome 12, where CSR occurs. Based on the genome instability detected by telomere FISH, we estimated that if chromosome 12 was targeted randomly, three breaks in this chromosome should be found among 50 metaphases and these breaks should be randomly distributed along the chromosome. In contrast with the latter prediction, we detected three to fi ve IgH locus-specifi c chromosome breaks in 50 metaphases ( Table I ). Considering that the IgH locus covers only ‫ف‬ 3% of chromosome 12, this implies that IgH locus-specifi c breaks in Pol -defi cient B cells The analysis of SHM in GC B cells by bulk PCR has been published previously ( 32, 33 ) . Splenic GC B cells were sorted into a naive fraction (CD19 + PNA low Fas low ) and a GC fraction (CD19 + PNA high Fas high ). PCR fragments corresponding to the intron downstream of J H 4 were obtained from DNA of purifi ed cell populations using the primers J558Fr3 and JHCHint-1 ( 46 ). PCR fragments containing VDJ rearrangements involving a J H 4 element were selected for further analysis, subcloned, and sequenced. A stretch of 500 bp of intron sequence immediately downstream of the J H 4 element was analyzed for somatic mutations.
Class switch analysis. B cells were purifi ed from splenic single cell suspensions by MACS depletion using anti-CD43 microbeads (Miltenyi Biotech). The cells were stimulated with either 20 μ g/ml LPS alone, 20 μ g/ml LPS and 25 ng/ml IL-4 (R & D Systems), or 1 μ g/ml anti-CD40 mAb (clone HM40-3; BD) and 25 ng/ml IL-4. Cells were cultured for 4 -5 d. The percentage of class-switched cells was determined between days 3 and 5 by fl ow cytometry. Proliferation was determined by labeling of the cells before stimulation with 2.5 mM CFSE in PBS and measuring the number of cell divisions on day 4 by fl ow cytometry. For the analysis of the switch junctions, DNA was isolated from the cells on day 3 and amplifi ed by a nested PCR reaction using the primers C 1.1 and C ␥ 1.1, followed by C 1.2 and C ␥ 1.2. PCR products with a length of 500 -800 nt were subcloned and subsequently sequenced. Clonally related sequences were excluded from the analysis.
Cytogenetic analysis. MACS-purifi ed B cells were stimulated with 20 μ g/ml LPS and 25 ng/ml IL-4 and cultured for 3 d, at which 50 ng/ml colcemid (KaryoMAX Solution; Invitrogen) was added to the medium for 2 h. The preparation of metaphases has been described elsewhere. In brief, the cells a targeting vector containing a loxP-fl anked exon 2. The culture and transfection of C57BL/6-derived Bruce4 ES cells has been described previously. Homologous recombination was determined by Southern hybridization of probe A with EcoRI-digested genomic DNA or of probe B with BamHIdigested genomic DNA. The latter assay was also used to ensure the integration of the third loxP site. After homologous recombination, the neomycin resistance gene was removed in vitro by transfection of ES cells with the Cre recombinase-expressing plasmid pIC-Cre. Two independently targeted ES cell clones were injected into CB.20-derived blastocysts, which were implanted into pseudo-pregnant CB.20 foster mice to generate chimeric mice. Both clones transmitted the targeted allele into the germline. The correct targeting was confi rmed by a nested PCR. The fi rst PCR round used the primers polz-1 [5 Ј -GTCCGTCTGCCATCAAGTCTAGCTTCAG-3 Ј ] and polz-2 [5 Ј -GGAAGCCCTGGATTTCATCACGCCATTG-3 Ј ], which anneal 5 Ј of the region of homology and 3 Ј of the second loxP site, respectively ( Fig. 1 B ) . Both the Pol + and Pol f allele yielded a PCR product of ‫ف‬ 5.2 kb. This was followed by an amplifi cation step of the gel-purifi ed PCR products using primers that fl ank each loxP site (fi rst loxP site: primers polz-3 . The primers polz-1 and polz-2 were also used for the amplifi cation of the Pol ⌬ allele from tail DNA of Pol +/ ⌬ mice. Parts of the PCR product (3.2 kb) were sequenced using the primers polz-1, polz-3, and polz-6 to confi rm the integration of the targeting vector into the Rev3 locus and the excision of exon 2.
Mice. Pol f/+ mice were intercrossed with deleter mice to obtain mice carrying a nonfunctional Pol allele ( Pol ⌬ /+ mice) ( 45 ) . Subsequent intercrosses between Pol f/+ mice, Pol ⌬ /+ mice, and CD21-cre mice generated Pol f/ ⌬ / CD21-cre mice ( 44 ) . The mice were kept on a C57BL/6 background. All mouse experiments were approved by the Institutional Animal Care and Use Committee of Harvard University and by the Immune Disease Institute.
Flow cytometry.
Single-cell suspensions prepared from lymphoid organs were stained with the following monoclonal antibodies conjugated to FITC, PE, CyC, APC, or biotin: anti-CD3 (145-2C11), anti-CD4 (L3T4), anti-CD8 (53 -6.7), anti-CD19 (ID3), anti-CD21, anti-CD23 (B3B4), anti-CD43 (S7), and anti-Fas (Jo2; BD). Monoclonal antibodies against IgM (R33-2412) and B220 (RA3-6B2) were prepared and conjugated in our laboratory. PNA conjugates were PNA-FITC or PNA-biotin (Vector Laboratories). Biotin conjugates were visualized with CyC or APC-streptavidin (BD). All samples were acquired on a FACSCalibur (BD) and analyzed using CellQuest software (BD).
Immunizations.
Mice were immunized by intraperitoneal injection with 100 μ g of alum-precipitated NP 36 -CG ((4-hydroxy-3-nitrophenyl)acetyl coupled to chicken ␥ -globulin; Biosearch Technologies, Inc.). NP-specifi c Ig serum titers were monitored every 7 d by bleeding of the mice from the tail vein and subsequent ELISA.
Deletion effi ciency of the Pol f allele in GC B cells. CD19 + PNA low Fas low naive and CD19 + PNA high Fas high GC B cells were sorted by FACS, subsequently lysed in 50 μ l of 10-mM Tris, ph 7.5, plus 250 μ g/ml proteinase K for 3 h at 56 ° C, and heat inactivated for 15 min at 80 ° C. Serial dilutions of 20,000 cell equivalents were used for the amplifi cation of the Pol f and Pol ⌬ alleles in a competitive PCR (30 s and 94 ° C denaturation; 30 s and 67 ° C annealing; and 1 min and 72 ° C elongation, 30 cycles) using the forward primers Seq1 (5 Ј -AAAGGTCAGCTGGTCAGAGTGAGGGA-3 Ј ) and Seq7 (5 Ј -ATGTAAAAGAATACAGTGGAAGTGAGG-3 Ј ), which anneal 5 Ј and within the floxed region, respectively, and the common reverse primer Seq2, 5 Ј -GGGAAGCCCTGGATTTCATCACG-3 Ј , which anneals 3 Ј of the fl oxed region. The ratios of the Pol f -and Pol ⌬ -derived PCR fragments were compared with a standard curve of known ratios to estimate the deletion effi ciency.
Online supplemental material. Fig. S1 contains the analysis of SHM in GC B cells of Pol f/ ⌬ /CD21-cre mice and control mice by bulk PCR. Table S1 shows the frequency of mutations in S μ and S ␥ 3 regions near S -S ␥ 3 junctions in Pol -defi cient and control B cells, and 
